BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 25764785)

  • 1. [Hyperprolactinemia unrelated to prolactinoma].
    Krysiak R; Okopień B
    Wiad Lek; 2014; 67(2 Pt 1):101-11. PubMed ID: 25764785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactinomas.
    Glezer A; Bronstein MD
    Endocrinol Metab Clin North Am; 2015 Mar; 44(1):71-8. PubMed ID: 25732643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperprolactinemia and prolactinoma.
    Romijn JA
    Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation of hyperprolactinemia.
    Luciano AA
    J Reprod Med; 1999 Dec; 44(12 Suppl):1085-90. PubMed ID: 10649815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient guide to hyperprolactinemia diagnosis and treatment.
    Hoffman AR; Melmed S; Schlechte J
    J Clin Endocrinol Metab; 2011 Feb; 96(2):35A-6A. PubMed ID: 21296988
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperprolactinemia in children: clinical features and long-term results.
    Catli G; Abaci A; Altincik A; Demir K; Can S; Buyukgebiz A; Bober E
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1123-8. PubMed ID: 23329759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Some issues in the diagnosis and treatment of hyperprolactinemia].
    Jin ZM
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):241-3. PubMed ID: 18843959
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical guidelines for diagnosis and treatment of prolactinoma and hyperprolactinemia].
    Halperin Rabinovich I; Cámara Gómez R; García Mouriz M; Ollero García-Agulló D;
    Endocrinol Nutr; 2013; 60(6):308-19. PubMed ID: 23477758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current diagnosis and treatment of hyperprolactinemia].
    Melgar V; Espinosa E; Sosa E; Rangel MJ; Cuenca D; Ramírez C; Mercado M
    Rev Med Inst Mex Seguro Soc; 2016; 54(1):111-21. PubMed ID: 26820213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic evaluation of hyperprolactinemia.
    Biller BM
    J Reprod Med; 1999 Dec; 44(12 Suppl):1095-9. PubMed ID: 10649817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperprolactinemia and prolactinomas.
    Mancini T; Casanueva FF; Giustina A
    Endocrinol Metab Clin North Am; 2008 Mar; 37(1):67-99, viii. PubMed ID: 18226731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of macroprolactinemia in the differential diagnosis of hyperprolactinemic patients.
    Bağdatoğlu C; Bağdatoğlu OT; Muslu N; Köseoğlu A; Dağtekin A; Polat G; Dolgun H; Karataş MA
    Turk Neurosurg; 2008 Jul; 18(3):223-7. PubMed ID: 18814107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acromegaly with moderate hyperprolactinemia caused by an intrasellar macroadenoma.
    Bonert VS; Melmed S
    Nat Clin Pract Endocrinol Metab; 2006 Jul; 2(7):408-12; quiz following 412. PubMed ID: 16932323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.
    Radavelli-Bagatini S; Lhullier FL; Mallmann ES; Spritzer PM
    Neuro Endocrinol Lett; 2013; 34(3):207-11. PubMed ID: 23685418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preface.
    Grineva E
    Neuroendocrinology; 2019; 109(1):5-6. PubMed ID: 31167201
    [No Abstract]   [Full Text] [Related]  

  • 17. Macroprolactinemia: new insights in hyperprolactinemia.
    Kasum M; Oreskovic S; Zec I; Jezek D; Tomic V; Gall V; Adzic G
    Biochem Med (Zagreb); 2012; 22(2):171-9. PubMed ID: 22838183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperprolactinemia. Evaluation and management.
    Blackwell RE
    Endocrinol Metab Clin North Am; 1992 Mar; 21(1):105-24. PubMed ID: 1349524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.
    Vilar L; Abucham J; Albuquerque JL; Araujo LA; Azevedo MF; Boguszewski CL; Casulari LA; Cunha Neto MBC; Czepielewski MA; Duarte FHG; Faria MDS; Gadelha MR; Garmes HM; Glezer A; Gurgel MH; Jallad RS; Martins M; Miranda PAC; Montenegro RM; Musolino NRC; Naves LA; Ribeiro-Oliveira Júnior A; Silva CMS; Viecceli C; Bronstein MD
    Arch Endocrinol Metab; 2018; 62(2):236-263. PubMed ID: 29768629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Forbes-Albright syndrome (prolactinoma)].
    Inoue T
    Nihon Rinsho; 2006 May; Suppl 1():151-4. PubMed ID: 16776115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.